VAMP regimen
Term · Oncology and biomedicine · MLC-T-ONC-009160
An abbreviation for a chemotherapy combination used with radiation therapy to treat low-risk childhood Hodgkin lymphoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), methotrexate, and prednisone. Also called VAMP.
A chemotherapy regimen consisting of vincristine, doxorubicin hydrochloride (Adriamycin), methotrexate and prednisone used in combination with radiation therapy for the treatment of low-risk childhood Hodgkin lymphoma.
| Identifier | MLC-T-ONC-009160 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | VAMP; vincristine-Adriamycin-methotrexate-prednisone regimen |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009160",
"term": "VAMP regimen",
"field": "Oncology and biomedicine",
"definitions": [
"An abbreviation for a chemotherapy combination used with radiation therapy to treat low-risk childhood Hodgkin lymphoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), methotrexate, and prednisone. Also called VAMP.",
"A chemotherapy regimen consisting of vincristine, doxorubicin hydrochloride (Adriamycin), methotrexate and prednisone used in combination with radiation therapy for the treatment of low-risk childhood Hodgkin lymphoma."
],
"synonyms": [
"VAMP",
"vincristine-Adriamycin-methotrexate-prednisone regimen"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/vamp-regimen/"
}
Record 17,100 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.